Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Ambient Audio-Visual Capture for Clinical Documentation and Assessment (BLACKFRAME-AV-)

10 giugno 2026 aggiornato da: BlackFrame.ai

Ambient Audio-Visual Capture for Clinical Documentation, Assessment and Feedback in Medical Education

AI-powered tools that automatically document clinical conversations are being adopted rapidly in outpatient settings but have not been evaluated in hospital wards. Existing tools use audio recording only, which cannot capture physical examination findings, procedural observations, or clinical safety behaviours - elements of a ward round that are visible but not audible.

This study evaluates an ambient audio-visual (AV) capture system - BlackFrame - that uses both microphone and camera to generate accurate clinical documentation and structured educational feedback in a real inpatient surgical ward setting.

Medical students and doctors in training participate in supervised ward round encounters with consenting adult inpatients. The BlackFrame AI platform generates: (a) a structured draft clinical note for the supervising clinician to review and countersign before any use in the patient record; and (b) formative feedback for the trainee, delivered within 30 minutes, covering clinical communication, examination technique, and documentation quality.

The study measures whether AI-generated feedback improves trainee clinical performance over a placement, how much documentation time is saved, and whether the system is acceptable to patients and clinicians. No AI-generated text enters the patient record without explicit clinician review and sign-off. All participation is voluntary.

Panoramica dello studio

Descrizione dettagliata

BACKGROUND

Ambient AI scribes have achieved rapid uptake in outpatient and community settings but all published evaluations use audio-only capture. The inpatient ward round is a multimodal clinical event comprising verbal exchange, physical examination, procedural assessment, and non-verbal observation. Audio-only systems are structurally incapable of capturing observable clinical elements, representing construct under-representation under the Messick validity framework.

No published study has evaluated ambient audio-visual capture in a real inpatient setting, nor measured the educational impact of AI-generated formative feedback on ward rounds.

STUDY DESIGN

Mixed-methods feasibility and educational impact study. Surgical ward round at Yeovil District Hospital as the primary study context. Up to three ambient AV capture devices deployed simultaneously in separate side rooms on each study day. Ward rounds proceed sequentially through each room, allowing up to three consented encounters per study day.

PARTICIPANTS

Trainee participants: medical students (Year 3-5) and doctors in training (FY1 through registrar/ST grade) undertaking supervised clinical activities at the study site.

Patient participants: adult inpatients (age 18 or over) able to provide informed consent, admitted under the surgical team, clinically stable at the time of approach.

TARGET SAMPLE: 60-80 consented encounters across 20-30 trainee participants and up to 80 patient participants.

INTERVENTION

On each study day, eligible patients in up to three side rooms are consented before ward rounds begin. A BlackFrame ambient AV capture device is positioned visibly in each consented patient's room prior to the ward round, with clear patient-facing signage. Devices operate autonomously once positioned and do not require operator presence during the encounter.

The surgical ward round proceeds sequentially through each side room. After each encounter the AI platform produces: (a) a structured draft clinical note for supervising clinician review and countersignature before any use in the patient record; (b) a formative feedback report for the trainee covering clinical communication, examination technique, and documentation quality, delivered within 30 minutes.

OUTCOMES

Primary: (1) Change in trainee assessment scores from baseline to end-of-placement; (2) documentation time saved with versus without AI s

Tipo di studio

Interventistico

Iscrizione (Stimato)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

Descrizione

Inclusion

Trainee participants:

  • Doctor in training (FY1 through registrar/ST grade) undertaking a supervised clinical activity at a participating NHS study site
  • Able to provide written informed consent in English

Patient participants:

  • Adult inpatient aged 18 years or over
  • Able to provide written informed consent in English
  • Admitted under a surgical team at a participating study site
  • Clinically stable at the time of approach

Exclusion

Trainee participants:

  • Unwilling to be audio-visually recorded
  • Unable to provide written informed consent
  • Any trainee where participation could create a direct conflict with a concurrent formal assessment or appraisal process at that session

Patient participants:

  • Age under 18 years
  • Unable to provide informed consent (including temporary incapacity due to acute illness, sedation, or delirium)
  • Acute clinical deterioration at the time of approach
  • Encounter involves sensitive disclosures in mental health, sexual health, or safeguarding unless a specific sub-protocol with additional consent measures is in place
  • Patient has previously declined participation and does not wish to be re-approached
  • Non-English speaking patients where no appropriate interpreter is available to support the consent process

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Trainee participants
Medical students (Year 3-5) and doctors in training (FY1 through registrar/ST grade) undertaking supervised clinical activities on the surgical ward at the study site. Participants receive AI-generated formative feedback within 30 minutes of each ward round encounter and complete baseline and follow-up clinical assessments.
Fixed camera and microphone array positioned visibly in the patient's room captures the ward round encounter. The AI platform processes the recording to generate: (a) a structured draft clinical note for supervising clinician review and countersignature; (b) a formative feedback report for the trainee covering clinical communication, examination technique, and documentation quality, delivered within 30 minutes of the encounter.
Sperimentale: Patient participants
Adult inpatients aged 18 or over admitted under the surgical team at the study site, able to provide informed consent and clinically stable at the time of approach. Patients consent to ambient AV recording of their ward round encounter. Their care is unaffected by participation.
Fixed camera and microphone array positioned visibly in the patient's room captures the ward round encounter. The AI platform processes the recording to generate: (a) a structured draft clinical note for supervising clinician review and countersignature; (b) a formative feedback report for the trainee covering clinical communication, examination technique, and documentation quality, delivered within 30 minutes of the encounter.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Mean documentation time per encounter with versus without AI scribe assistance
Lasso di tempo: Through study completion, approximately 12 weeks
mean difference in time (minutes) to produce a clinical ward round note with versus without AI scribe assistance. Analysed using paired comparison with 95% confidence interval.
Through study completion, approximately 12 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Cohen's kappa between AI-generated and expert human assessment scores per checklist domain
Lasso di tempo: Through study completion, approximately 12 weeks
Cohen's kappa coefficient between AI-generated and independent expert human assessment scores, reported per checklist domain
Through study completion, approximately 12 weeks
Trainee-rated feedback quality score on 5-item Likert survey
Lasso di tempo: After first study encounter, approximately within 1 week of study enrolment
trainee-rated feedback quality, perceived fairness, and utility (5-item Likert survey)
After first study encounter, approximately within 1 week of study enrolment
Blinded expert rating of AI-assisted clinical note completeness and accuracy
Lasso di tempo: Through study completion, approximately 12 weeks
Structured rating score comparing AI-assisted versus standard ward round note on completeness, accuracy, and clinical safety content, rated by blinded clinical expert assessors
Through study completion, approximately 12 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 settembre 2026

Completamento primario (Stimato)

30 novembre 2026

Completamento dello studio (Stimato)

30 novembre 2026

Date di iscrizione allo studio

Primo inviato

1 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 giugno 2026

Primo Inserito (Effettivo)

16 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

16 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

Descrizione del piano IPD

As per protocol

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Educazione medica

Sottoscrivi